Multiple vector impedance measurements during biventricular pacing: feasibility and possible implications for hemodynamic monitoring.

BACKGROUND: Intracardiac impedance (ICZ) has been known to reflect contractile capacity of the heart, and a strong relationship has been documented between stroke volume and ICZ. In this pilot study, conducted in heart failure patients during implantation of a biventricular device, we investigated acute changes in multiple vector ICZ signals during different pacing modes, and whether ICZ can be used to monitor hemodynamic variations. METHODS: Z1 and Z2 impedance signals were recorded in the right ventricle (RV), and between the left ventricle (LV) and RV, respectively, in 12 patients during four programming modes. ICZ signals were analyzed with respect to average and peak-to-peak (p2p) amplitude and systolic slope, and correlated with noninvasive hemodynamic and echocardiographic variables. RESULTS: ICZ p2p amplitude decreased during LV stimulation both in Z1 and in Z2 configuration (P = 0.021 and P = 0.022 vs intrinsic conduction, respectively). No significant variations in average amplitude or systolic slope were observed. ICZ variables correlated directly with hemodynamic measures (r = 0.48, P < 0.05, between Z2 p2p amplitude and pulse pressure), LV ejection fraction (r = 0.32, P < 0.05, for Z1 average amplitude), RV ejection fraction (r = 0.75, P < 0.05, for Z1 p2p amplitude), and inversely with ventricular volumes. CONCLUSIONS: Variations in ICZ may be observed during different pacing modes and seem to correlate with hemodynamic and echocardiographic variables. Multiple vector ICZ measurement may be a feasible tool for hemodynamic assessment in patients treated with biventricular pacing.

Usefulness of monitoring congestive heart failure by multiple impedance vectors.

INTRODUCTION: We investigated trends in intrathoracic impedance measured between multiple implanted electrodes for monitoring pulmonary edema secondary to congestive heart failure (CHF) in an experimental model. METHODS: Biventricular ICDs were implanted in 16 dogs and 5 sheep. Continuous RV pacing (230- 250 bpm) was applied over several weeks. Meanwhile, impedance was measured every hour along 4 intrathoracic and 2 intracardiac vectors. Four cardiogenic impedance vectors were also monitored. Cardiac function was assessed biweekly by catheterization and echocardiography. Left atrial (LA) pressure was measured daily by an implanted LA pressure sensor. RESULTS: All animals developed CHF after 2-4 weeks of pacing as evidenced by changes in function (EF, 52 vs. 34%; LV end-diastolic volume, 65 vs. 97 ml; LV end-diastolic pressure, 7 vs. 16 mmHg; LA volume, 17 vs. 33 ml; LA pressure, 7 vs. 26 mmHg), clinical symptoms, or autopsy. Steady state impedance decreased during CHF: LV-Can, 17+/-9%; LV-RV, 15+/-8%; LV-RA, 13+/-6%; RV-Can, 13+/-8%; RVcoil-Can, 8+/-6%; RA-Can, 6+/-6%. Change in LV-Can impedance was greater than that of RA-Can, RV-Can, and RVcoil-Can (P0.05). LV-Can impedance correlated well with LA pressure (r(2)=0.73), while RV-Can and RVcoil-Can were weakly correlated (r(2)=0.43 and r(2)=0.52, respectively). Changes in LV-RV and LV-RA impedances were also larger than those of RVcoil-Can and RA-Can (P0.05). Meanwhile, all impedances were associated with circadian variability at baseline (5+/-2%) which diminished during CHF (2+/-1%); P=0.02. Furthermore, significant variations were observed in cardiogenic impedances during progression into CHF as evidenced by reduced peak-to-peak amplitude and increased fractionation of the signals. CONCLUSIONS: All impedance vectors decreased during CHF. Impedance measurement employing left heart sensors correlated well wit- - h LA pressure, and may improve detection of CHF onset compared to sensing by RA or RV leads alone. This approach has important clinical implications for managing heart failure patients in the ambulatory setting.

Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads.

Immunohistochemical and morphologic techniques were employed to evaluate the tissue response around chronically implanted pacing leads. Seventeen leads were retrieved from 12 patients. Leads were extracted by direct manual traction (1), extraction with sheaths and locking stylets (1), or with by a combination of mechanical tools and Excimer laser sheaths (15). Mean lead implantation time was 5.6 years (range 1-8 years). Frozen sections, 6-8 microm thick, were incubated with antibodies against HLA-DR antigen, endothelial cells, macrophages, T cells, plasma cells, fibrinogen, and interleukin-1beta. Prominent morphologic observations were fibrous encapsulations of the leads. Immunohistochemical analysis revealed a tissue generally devoid of inflammatory and immune cells. The fibrous capsule surrounding the lead was partially or completely covered with a monolayer of CD34 expressing endothelial cells. The results from this study provide useful information in design and material selection for pacemaker leads. Endothelialization of the fibrous encapsulation indicates a functionalization of blood-contacting surfaces around pacemaker materials, thus providing a mechanism for long-term persistence of foreign materials in the blood. The laser method allowed an efficient extraction of pacemaker leads without damage to the studied tissues, as suggested by the presence of immunolabeled cells close to the cut surfaces.

Atrial evoked response integral for automatic capture verification in atrial pacing.

Beat-by-beat Autocapture is currently limited to operation in the ventricle with bipolar leads. The authors investigated the integral of the negative-going portion of the atrial evoked response integral (AERI) as a potential resource for verification of atrial capture. Intracardiac electrogram signals were collected from 59 patients (ages 67.8 +/- 15.1 years) with bipolar, low polarization atrial leads. The signals were collected over a mean period of 6.1 months (minimum 4 days) after lead implantation. St. Jude Medical Affinity pulse generators were used to perform automatic capture threshold tests while the electrogram signals were recorded by a Model 3510 programming device. These signals were transferred to a personal computer in digital form for later analysis. The AERI was calculated at each programmable pacing voltage until capture was lost. The difference between the polarization integral at loss of capture and evoked response integral with successful capture was sufficient to justify enabling the atrial Autocapture feature in 53 of 59 patients in whom bipolar pacing and unipolar sensing was performed. The authors developed a calibration routine to identify automatically those patients in whom atrial Autocapture could be programmed On, based on the polarization integral at loss of capture, the estimated maximum polarization integral, and the AERI. Preliminary analysis indicated that the AERI is a practical resource for beat-by-beat atrial capture detection when used with low polarization leads.

Autocapture enhancements: unipolar and bipolar lead compatibility and bipolar pacing capability on bipolar leads.

Beat-by-beat Autocapture maximizes device longevity by minimizing stimulus amplitude while assuring patient safety. Currently, Autocapture permits use of only bipolar leads. The authors have devised a detection method that operates with unipolar and bipolar leads and covers all pacing and sensing combinations (but bipolar pace and sense simultaneously). This new detection method for unipolar sensing uses the integral of the negative portion of the unipolar evoked response as a robust capture detection feature. When using bipolar leads, the method provides the flexibility of bipolar or unipolar pacing. In this study, unipolar ventricular intracardiac electrograms (EGMs) were recorded in 71 patients, 73.7 +/- 9.9 years of age; 9 with high polarization, 62 with low polarization. High polarization had polished platinum or activated carbon electrodes. Low polarization had TiN, platinized platinum, or IrOx electrodes. The intracardiac EGMs were recorded 544 +/- 796 days after implant. The pacemakers performed an automatic capture threshold test while the intracardiac EGM signals were recorded in a programmer. These digitized signals were saved for off-line analysis. The unipolar evoked response was calculated at up to six (depending on capture threshold) pacing voltages and the polarization integral at 4.5 V and at loss of capture. An automatic calibration algorithm determined if the signal-to-noise ratio was adequate for Autocapture operation. Autocapture was possible with 60 of 62 of the low polarizations, and with 6 of 9 of the high polarizations. The average values form the data collected were: average unipolar evoked response--4.1 +/- 2.1 mV, average peak negative voltage--10.0 +/- 3.7 mV, average polarization 0.3 +/- 0.34 mV, and average signal-to-noise ratio (unipolar evoked response/ polarization) 38 +/- 71. In all cases the algorithm correctly determined the appropriateness of using Autocapture with the electrodes tested and the unipolar evoked response threshold to be used.